Dual role of signaling pathways in myeloma requires cell type-specific targeting of ligand-receptor interactions

Pablo Hernandez-Lopez1, Tushara Vijaykumar1, Praveen Anand1,2,3

  • 1Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA.

Blood Advances
|April 11, 2024
PubMed

Insights

Immune cell interactions in multiple myeloma impact treatment response. Targeting specific cellular contexts within the immune microenvironment is crucial for effective therapies against this blood cancer.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Multiple myeloma (MM) patients often develop therapy resistance, limiting durable responses to immunomodulatory treatments.
  • The immune microenvironment's composition is not routinely used for prognosis in MM.
  • Immune signaling pathway outcomes may vary based on interacting cell types, suggesting context-dependent prognostic and therapeutic implications.

Purpose of the Study:

  • To investigate the prognostic and therapeutic implications of immune signaling pathways in multiple myeloma.
  • To explore how cellular context influences immune pathway engagement in MM.
  • To identify potential prognostic markers within the immune microenvironment.

Main Methods:

  • Analysis of immune cell composition and gene expression profiles in a cohort of 25 newly diagnosed multiple myeloma patients.
  • Examination of regulatory networks within the immune compartment.
  • Investigation of molecular interactions within the immune microenvironment.

Main Results:

  • Significant differences in the B-cell compartment were associated with treatment response in MM patients.
  • Patients with a short time to progression showed enrichment of pathways related to B-cell differentiation and inflammation, suggesting immune dysfunction.
  • Molecular interactions within the immune microenvironment demonstrated a dual role for signaling pathways, correlating with either good or poor prognosis based on cell types.

Conclusions:

  • The cellular context of immune interactions is critical for determining prognostic and therapeutic outcomes in multiple myeloma.
  • Targeting ligand-receptor interactions requires consideration of the specific microenvironment composition and involved cell types.
  • Immune microenvironment profiling may offer novel prognostic markers and guide personalized therapeutic strategies in multiple myeloma.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Overview of Cell Signaling01:23

Overview of Cell Signaling

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate with the environment.
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...
20.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
8.5K